189 related articles for article (PubMed ID: 31671217)
1. A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia.
Honda S; Tsujimoto M; Minegaki T; Mori T; Muraoka J; Nishiguchi K
J Clin Pharm Ther; 2020 Apr; 45(2):373-375. PubMed ID: 31671217
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer.
Kato N; Nakai T; Kodama S; Koyama S; Nakane S; Wada Y; Oda H; Katayama H; Mase H; Miyagawa Y; Miyazaki M; Yamada S; Yamada K
In Vivo; 2024; 38(3):1243-1252. PubMed ID: 38688620
[TBL] [Abstract][Full Text] [Related]
3. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia.
Overman MJ; Ferrarotto R; Raghav K; George B; Qiao W; Machado KK; Saltz LB; Mazard T; Vauthey JN; Hoff PM; Hobbs B; Loyer EM; Kopetz S
J Natl Cancer Inst; 2018 Aug; 110(8):888-894. PubMed ID: 29346573
[TBL] [Abstract][Full Text] [Related]
4. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
Curtis SA; Curtis BR; Lee AI; Hendrickson JE; Lacy J; Podoltsev NA
Hematology; 2018 Aug; 23(7):429-432. PubMed ID: 29281948
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
6. [Successful management using laparoscopic splenectomy for splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced rectal cancer].
Koike N; Ohshima Y; Takeuchi T; Arita S; Shinozaki E
Gan To Kagaku Ryoho; 2013 Jun; 40(6):815-7. PubMed ID: 23863666
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin-induced hepatocellular injury and ototoxicity: a review of the literature and report of unusual side effects of a commonly used chemotherapeutic agent.
Vietor NO; George BJ
J Oncol Pharm Pract; 2012 Sep; 18(3):355-9. PubMed ID: 22333669
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer.
Taguchi R; Tsuchihashi K; Okumura Y; Nakano M; Yoshihiro T; Ohmura H; Tsuruta N; Hanamura F; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
Intern Med; 2020; 59(20):2571-2575. PubMed ID: 33055471
[TBL] [Abstract][Full Text] [Related]
9. Spleen Volume as a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy.
Miyata T; Takamura H; Kin R; Nishiki H; Hashimoto A; Fujii Y; Miura S; Fujita J; Kaida D; Tomita Y; Nakamura N; Fujita H; Kinami S; Ueda N; Kosaka T
Anticancer Res; 2020 Jun; 40(6):3361-3370. PubMed ID: 32487632
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Anaphylactic Shock after First Administration of Oxaliplatin].
Shiota T; Okamura R; Nakayama H; Kato T; Kito Y; Sata R
Gan To Kagaku Ryoho; 2019 Sep; 46(9):1433-1435. PubMed ID: 31530784
[TBL] [Abstract][Full Text] [Related]
12. Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.
Vyskocil J; Tucek S; Kiss I; Fedorova L; Nevrlka J; Zdrazilova-Dubska L
Int Immunopharmacol; 2019 Sep; 74():105728. PubMed ID: 31288153
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin and Methylprednisolone-induced Thrombocytopenia and Monocytopenia, Owing to Anti-GPIIbIIIa and -CD36 Antibodies in a Patient With Colorectal Cancer.
Laurichesse M; Pedrono M; Guilleray G; Gallienne L; Cherel M; Schmitt F; Renac V; Bertrand G
Clin Colorectal Cancer; 2020 Dec; 19(4):e277-e280. PubMed ID: 32727666
[No Abstract] [Full Text] [Related]
14. Liver cirrhosis following oxaliplatin-based adjuvant chemotherapy for rectal cancer.
Huang C; Chen J; Situ Y
J Oncol Pharm Pract; 2023 Sep; 29(6):1520-1524. PubMed ID: 37226315
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury.
Borlak J; van Bömmel F; Berg T
Liver Int; 2018 Feb; 38(2):365-376. PubMed ID: 28782153
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Colon Cancer with DPD Deficiency That Showed Severe Myelosuppression by CapeOX Adjuvant Chemotherapy after Colon Resection].
Watanabe H; Arita S; Takeuchi T; Oshima Y; Koike N
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1661-1664. PubMed ID: 30449859
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.
Hong YS; Kim SY; Lee JS; Nam BH; Kim KP; Kim JE; Park YS; Park JO; Baek JY; Kim TY; Lee KW; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
J Clin Oncol; 2019 Nov; 37(33):3111-3123. PubMed ID: 31593484
[TBL] [Abstract][Full Text] [Related]
19. S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
Hong YS; Park YS; Lim HY; Lee J; Kim TW; Kim KP; Kim SY; Baek JY; Kim JH; Lee KW; Chung IJ; Cho SH; Lee KH; Shin SJ; Kang HJ; Shin DB; Jo SJ; Lee JW
Lancet Oncol; 2012 Nov; 13(11):1125-32. PubMed ID: 23062232
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer.
Takano Y; Furune S; Miyai Y; Morita S; Inoue M; Shimokata T; Sugishita M; Mitsuma A; Maeda O; Ando Y
Int Cancer Conf J; 2022 Jan; 11(1):67-70. PubMed ID: 35116219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
